| |
| |
|
| Insider
Information: |
Noblett Karen |
| Relationship: |
|
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
34,428 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,317,693 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
34,428 |
|
|
| Total
Value |
$2,317,693 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -36.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Axonics Modulation Technologies,... |
AXNX |
|
2024-01-31 |
34,428 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2024-01-31 |
4 |
S |
$67.74 |
$764,603 |
D/D |
(11,288) |
34,428 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,500 |
45,716 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2024-01-08 |
4 |
AS |
$69.00 |
$1,103,961 |
D/D |
(15,999) |
18,216 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2023-12-28 |
4 |
AS |
$63.28 |
$446,177 |
D/D |
(7,051) |
34,215 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2023-12-26 |
4 |
AS |
$63.00 |
$59,787 |
D/D |
(949) |
41,266 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2023-02-01 |
4 |
S |
$60.43 |
$56,727 |
D/D |
(931) |
42,215 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2023-01-31 |
4 |
S |
$61.12 |
$226,437 |
D/D |
(3,703) |
43,146 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2023-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,250 |
46,849 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
36,599 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2022-09-12 |
4 |
S |
$78.16 |
$2,538,800 |
D/D |
(32,483) |
31,599 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2022-09-12 |
4 |
OE |
$14.19 |
$623,335 |
D/D |
32,483 |
64,082 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2022-09-07 |
4 |
S |
$71.53 |
$747,794 |
D/D |
(10,454) |
31,599 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2022-03-18 |
4 |
S |
$57.23 |
$774,359 |
D/D |
(13,531) |
42,053 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2022-02-03 |
4 |
S |
$48.21 |
$322,421 |
D/D |
(6,682) |
55,584 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2022-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,463 |
62,266 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,350 |
42,803 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Medical Officer |
• – – |
2019-07-23 |
4 |
OE |
$0.98 |
$18,017 |
D/D |
14,404 |
54,124 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
